Development of a transformation system for chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector
Development of a transformation system for chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector
Chlamydia trachomatis remains one of the few major human pathogens for which there is no transformation system. C. trachomatis has a unique obligate intracellular developmental cycle. The extracellular infectious elementary body (EB) is an infectious, electron-dense structure that, following host cell infection, differentiates into a non-infectious replicative form known as a reticulate body (RB). Host cells infected by C. trachomatis that are treated with penicillin are not lysed because this antibiotic prevents the maturation of RBs into EBs. Instead the RBs fail to divide although DNA replication continues. We have exploited these observations to develop a transformation protocol based on expression of ?-lactamase that utilizes rescue from the penicillin-induced phenotype. We constructed a vector which carries both the chlamydial endogenous plasmid and an E.coli plasmid origin of replication so that it can shuttle between these two bacterial recipients. The vector, when introduced into C. trachomatis L2 under selection conditions, cures the endogenous chlamydial plasmid. We have shown that foreign promoters operate in vivo in C. trachomatis and that active ?-lactamase and chloramphenicol acetyl transferase are expressed. To demonstrate the technology we have isolated chlamydial transformants that express the green fluorescent protein (GFP). As proof of principle, we have shown that manipulation of chlamydial biochemistry is possible by transformation of a plasmid-free C. trachomatis recipient strain. The acquisition of the plasmid restores the ability of the plasmid-free C. trachomatis to synthesise and accumulate glycogen within inclusions. These findings pave the way for a comprehensive genetic study on chlamydial gene function that has hitherto not been possible. Application of this technology avoids the use of therapeutic antibiotics and therefore the procedures do not require high level containment and will allow the analysis of genome function by complementation
e1002258
Wang, Yibing
a4dc0303-7006-411e-9063-c26297fac847
Kahane, Simona
d74091ff-89e9-4c75-8a01-1da5315fb5e9
Cutcliffe, Lesley T
6b9ffde7-e521-4e76-abc5-95f913ef1768
Skilton, Rachel J
b02d4f32-609c-4074-b616-ec819b018dbe
Lambden, Paul R
7f3db3e6-beaa-44ab-9780-f378a106e632
Clarke, Ian N
ff6c9324-3547-4039-bb2c-10c0b3327a8b
22 September 2011
Wang, Yibing
a4dc0303-7006-411e-9063-c26297fac847
Kahane, Simona
d74091ff-89e9-4c75-8a01-1da5315fb5e9
Cutcliffe, Lesley T
6b9ffde7-e521-4e76-abc5-95f913ef1768
Skilton, Rachel J
b02d4f32-609c-4074-b616-ec819b018dbe
Lambden, Paul R
7f3db3e6-beaa-44ab-9780-f378a106e632
Clarke, Ian N
ff6c9324-3547-4039-bb2c-10c0b3327a8b
Wang, Yibing, Kahane, Simona, Cutcliffe, Lesley T, Skilton, Rachel J, Lambden, Paul R and Clarke, Ian N
(2011)
Development of a transformation system for chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector.
PLOS Pathogens, 7 (9), .
(doi:10.1371/journal.ppat.1002258).
(PMID:21966270)
Abstract
Chlamydia trachomatis remains one of the few major human pathogens for which there is no transformation system. C. trachomatis has a unique obligate intracellular developmental cycle. The extracellular infectious elementary body (EB) is an infectious, electron-dense structure that, following host cell infection, differentiates into a non-infectious replicative form known as a reticulate body (RB). Host cells infected by C. trachomatis that are treated with penicillin are not lysed because this antibiotic prevents the maturation of RBs into EBs. Instead the RBs fail to divide although DNA replication continues. We have exploited these observations to develop a transformation protocol based on expression of ?-lactamase that utilizes rescue from the penicillin-induced phenotype. We constructed a vector which carries both the chlamydial endogenous plasmid and an E.coli plasmid origin of replication so that it can shuttle between these two bacterial recipients. The vector, when introduced into C. trachomatis L2 under selection conditions, cures the endogenous chlamydial plasmid. We have shown that foreign promoters operate in vivo in C. trachomatis and that active ?-lactamase and chloramphenicol acetyl transferase are expressed. To demonstrate the technology we have isolated chlamydial transformants that express the green fluorescent protein (GFP). As proof of principle, we have shown that manipulation of chlamydial biochemistry is possible by transformation of a plasmid-free C. trachomatis recipient strain. The acquisition of the plasmid restores the ability of the plasmid-free C. trachomatis to synthesise and accumulate glycogen within inclusions. These findings pave the way for a comprehensive genetic study on chlamydial gene function that has hitherto not been possible. Application of this technology avoids the use of therapeutic antibiotics and therefore the procedures do not require high level containment and will allow the analysis of genome function by complementation
Other
fetchObject.action_uri=info_doi%2F10.1371%2Fjournal.ppat.1002258&representation=PDF
- Version of Record
Available under License Other.
More information
Published date: 22 September 2011
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 202093
URI: http://eprints.soton.ac.uk/id/eprint/202093
ISSN: 1553-7366
PURE UUID: 7c924da5-7717-4a7d-ac21-c5586ac10559
Catalogue record
Date deposited: 03 Nov 2011 15:28
Last modified: 15 Mar 2024 02:33
Export record
Altmetrics
Contributors
Author:
Yibing Wang
Author:
Simona Kahane
Author:
Lesley T Cutcliffe
Author:
Rachel J Skilton
Author:
Paul R Lambden
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics